S. Stephenson

发表

Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.

S. Hunt, J. Lalouel, P. Hopkins, 1988, JAMA.

Predictors of an Increased Risk of Future Hypertension in Utah A Screening Analysis

S. Hunt, P. Hopkins, Roger R. Williams, 1991, Hypertension.

A Distinct Fatty Acid Profile Underlies the Reduced Inflammatory State of Metabolically Healthy Obese Individuals

A. Badawi, A. Buchholz, D. Mutch, 2014, PloS one.

Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred

M. Emi, S. Hunt, P. Hopkins, 2002, Journal of Human Genetics.

Benefits of the MEDPED treatment support program for patients with familial hypercholesterolemia.

P. Hopkins, S. Stephenson, Stacey Larrinaga-Shum, 2009, Journal of clinical lipidology.

Familial hypercholesterolemia in Utah kindred with novel 2412-6 Ins G mutations in exon 17 of the LDL receptor gene.

T. Nakajima, M. Emi, P. Hopkins, 1999, Japanese heart journal.

Primordial prevention of cardiovascular disease through applied genetics.

S. Hunt, P. Hopkins, R. Williams, 1999, Preventive medicine.

Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia.

W. Riley, S. Hunt, P. Hopkins, 2001, The American journal of cardiology.

Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred

M. Emi, S. Hunt, P. Hopkins, 2004, Journal of Human Genetics.

Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia: a molecular study in an eight-generation hyperlipidemic family.

M. Emi, S. Hunt, P. Hopkins, 2003, Journal of atherosclerosis and thrombosis.

Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: Intra‐familial association study in an eight‐generation hyperlipidemic kindred

M. Emi, S. Hunt, P. Hopkins, 2003, American journal of medical genetics. Part A.

Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary.

A. Czeizel, L. Romics, R. Williams, 2001, Atherosclerosis.

A novel LDLR mutation, H190Y, in a Utah kindred with familial Hypercholesterolemia

T. Nakajima, M. Emi, P. Hopkins, 1999, Journal of Human Genetics.

Familial hypercholesterolemia in Utah kindred with novel R103W mutations in exon 4 of the LDL receptor gene.

T. Nakajima, M. Emi, P. Hopkins, 1999, Japanese Heart Journal.

G‐substrate gene promoter SNP (−1323T>C) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: Intra‐familial association study in an eight‐generation hyperlipidemic kindred

M. Emi, S. Hunt, P. Hopkins, 2004 .

Co-segregation of elevated LDL with a novel mutation (D92K) of the LDL receptor in a kindred with multiple lipoprotein abnormalities

T. Nakajima, M. Emi, P. Hopkins, 2000, Journal of Human Genetics.

A prospective study of sodium-lithium countertransport and hypertension in Utah.

S. Hunt, P. Hopkins, R. Williams, 1991, Hypertension.

Serum and adipose tissue amino acid homeostasis in the metabolically healthy obese.

D. Mutch, P. Britz‐McKibbin, F. Badoud, 2014, Journal of proteome research.